Evidence map›Paper›PMID 36771693›Full record

ArticlePlants (Basel, Switzerland)2023

Screening Evaluation of Antiproliferative, Antimicrobial and Antioxidant Activity of Lichen Extracts and Secondary Metabolites In Vitro.

Martin Kello, Michal Goga, Klaudia Kotorova, Dominika Sebova, Richard Frenak, Ludmila Tkacikova, Jan Mojzis

Abstract read
In one paragraph

Article in Plants (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Secondary metabolites fromRSC advances · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Unassuming Lichens: Nature's Hidden Antimicrobial Warriors.International journal of molecular sciences · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Martin KelloDepartment of Pharmacology, Faculty of Medicine, Pavol Jozef Šafárik University, 040 01 Košice, Slovakia.ORCID 0000-0002-2454-5799
Michal GogaDepartment of Botany, Institute of Biology and Ecology, Faculty of Science, Pavol Jozef Šafárik University, 041 67 Košice, Slovakia.ORCID 0000-0001-9517-158X
Klaudia KotorovaDepartment of Pharmacology, Faculty of Medicine, Pavol Jozef Šafárik University, 040 01 Košice, Slovakia.
Dominika SebovaDepartment of Pharmacology, Faculty of Medicine, Pavol Jozef Šafárik University, 040 01 Košice, Slovakia.
Richard FrenakDepartment of Botany, Institute of Biology and Ecology, Faculty of Science, Pavol Jozef Šafárik University, 041 67 Košice, Slovakia.ORCID 0000-0003-3279-2148
Ludmila TkacikovaDepartment of Microbiology and Immunology, University of Veterinary Medicine and Pharmacy, 041 81 Košice, Slovakia.ORCID 0000-0002-4551-3577
Jan MojzisDepartment of Pharmacology, Faculty of Medicine, Pavol Jozef Šafárik University, 040 01 Košice, Slovakia.ORCID 0000-0002-7974-4525

Funding

Grant Agency of the Ministry of the Education, Science, Research and Sport of the Slovak Republic KEGA 006UPJŠ-4/2020Grant Agency of the Ministry of the Education, Science, Research and Sport of the Slovak Republic VEGA 1/0539/21Grant Agency of the Ministry of the Education, Science, Research and Sport of the Slovak Republic VEGA 1/0653/19Grant Agency of the Ministry of the Education, Science, Research and Sport of the Slovak Republic VEGA 1/0753/17Operational Programme Integrated Infrastructure, funded by the ERDF ITMS2014+: 313011V455 OPENMEDSlovak Research and Development Agency APVV-16-0446
6 · The paper itself

Abstract

Lichen metabolites represent a wide range of substances with a variety of biological effects. The present study was designed to analyze the potential antiproliferative, antimicrobial and antioxidative effects of several extracts from lichens (

Indexed as

2D3D spheroidsantibacterialantioxidantcytotoxicitylichenssecondary metabolites

Identifiers

PMID36771693
PMCPMC9919983

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.